DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Eriksson BI, Turpie AG, Lassen MR. , et al; ONYX Study Group.
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery.
J Thromb Haemost 2007;
5 (08) 1660-1665
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.